TRT

Welcome to the Brand page for “TRT”, which is offered here for Tissue regeneration technologies;shockwave service for medical patients in the treatment of cirrhosis of the liver, cancer, myelodysplasia, stomach ulcers, aids, alzheimer's disease, bone cancer, arthritis, emphysema, gout, rheumatic disease, hiv, leprosy, lupus, skin sarcomas, cellulitis, melanomas, osteoporosis, periodontal diseases, pseudoarthrosis, wounds, scars, acne, bums, diabetes, cystic fibrosis, nerve paraplegia and enhancing stem cell reactions;research and clinical trials for shockwave treatments;.

Its status is currently believed to be active. Its class is unavailable. “TRT” is believed to be currently owned by “Tissue Regeneration Technologies”.